
Should COVID Vaccines Be Given Yearly?
Some scientists say the U.S. Food and Drug Administration’s suggestion of updating COVID vaccines each year, as happens with influenza vaccines, could boost uptake. But others are less convinced...
Max Kozlov is a science journalist at Nature whose work has appeared in the Atlantic, Nature, Quanta Magazine and Science, among other publications.
Some scientists say the U.S. Food and Drug Administration’s suggestion of updating COVID vaccines each year, as happens with influenza vaccines, could boost uptake. But others are less convinced...
Public health leader Anthony Fauci advises early-career researchers “not to be deterred” by vitriol
Controversy surrounding a study that involved modifying SARS-CoV-2, the virus that causes COVID, has prompted researchers to call for better guidance from funders
Thousands of tumor samples provide the clearest link yet between cancer and fungi, but more research is needed
The antiviral Tecovirimat (TPOXX) shows promise against monkeypox, but human data and supplies are limited
From the AIDS epidemic to the COVID-19 pandemic, the iconic medical chief has advised seven presidents on numerous outbreaks
Researchers are racing to understand the latest monkeypox outbreaks—from their origins to whether they can be contained
Researchers hope they could one day be used as a routine clinical tool by physicians.
The U.S. Department of Justice announced major changes to the espionage-protection program, but scientists hope for further acknowledgment of the damage done
After long delay, U.S. President Joe Biden picks Robert Califf to once again head the U.S. Food and Drug Administration
Immune cells might abort SARS-CoV-2 infection, forestalling a positive PCR or antibody test, a study in hospital workers suggests
Synapse genes help cells to communicate in a sponge’s digestive chambers
As U.S. Food and Drug Administration advisers recommend authorizing shots for children aged five to 11, researchers predict what this might mean for populations
The risk of severe disease dropped by factor of almost 20 in people over 60—but some dispute the benefits of offering an additional dose
Using machine learning, researchers created a tool that might help doctors improve people’s healthy lifespan
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account